Showing results (611-620 of 635) with videos related to

Sort By:
Pageof 64
Science Advances|May 29, 2024
Rejuvenation of peripheral immune cells attenuates Alzheimer's disease-like pathologies and behavioral deficits in a mouse modelPu-Yang Sun, Jie Liu, Jian-Ni Hu, et al.
Medcomm|June 23, 2025
Associations of Plasma and CSF Osteocalcin Levels With CSF ATN Biomarkers and Cognitive Functions in Alzheimer's DiseaseXian-Le Bu, Zhuo-Ting Liu, Jia-Yan Xin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2015
miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate CancerChao Cai, Qing-Biao Chen, Zhao-Dong Han, et al.
Radiology|March 11, 2020
Performance of Radiologists in Differentiating COVID-19 from Non-COVID-19 Viral Pneumonia at Chest CTHarrison X Bai, Ben Hsieh, Zeng Xiong, et al.
Acta Pharmacologica Sinica|June 17, 2025
Circular RNA circDhx32 promotes cardiac inflammatory responses in mouse cardiac ischemia-reperfusion injury via binding to FOXO1 competed with AdipoR1Wei Si, Chun-Lei Wang, Ling-Hua Zeng, et al.
Acta Pharmacologica Sinica|January 19, 2026
Zinc finger BED-type containing 6 (ZBED6) ameliorates cardiac fibrosis by inhibiting Piezo1 transcription and YAP nuclear translocationHan Wu, Wei-Tao Jiang, Qiao-Yue Zhao, et al.
Acta Neuropathologica|March 25, 2023
Physiological β-amyloid clearance by the liver and its therapeutic potential for Alzheimer's diseaseYuan Cheng, Chen-Yang He, Ding-Yuan Tian, et al.
JAMA Oncology|August 14, 2020
Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical TrialKe-Da Yu, Fu-Gui Ye, Min He, et al.
BMJ (Clinical Research Ed.)|October 23, 2024
Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trialMin He, Yi-Zhou Jiang, Yue Gong, et al.
Signal Transduction and Targeted Therapy|June 18, 2026
Spatially interpretable artificial intelligence framework to tailored neoadjuvant dual HER2 blockade in HER2-positive breast cancerXiang-Rong Wu, Hong Lv, Shen Zhao, et al.
Pageof 64